Contact: +91-9711224068
  • Printed Journal
  • Indexed Journal
  • Refereed Journal
  • Peer Reviewed Journal
International Journal of Pharmacognosy and Clinical Research

Vol. 1, Issue 1, Part A (2019)

A review on hebral remedies used for viral infection, HIV and liver disorder

Author(s):

Goswami Raksha, Kumawat Deepak, Gupta Durgesh Kumari, Shrivastava Darshana, Kumawat Priyanka

Abstract:

The rising number of patients with viral infection, HIV, and liver disorder was noticed due to overwhelming usage of drugs has paved the path for researchers in an interest in herbal medicines. These diseases still remain an area of medicine for which specific treatments are lacking. Herbal medicines provide rational means for the treatment of these diseases. Herbal medicines can be developed as a safe, effective and economical alternate. The herbal drugs which are used for treatment of viral infection are Ginseng, Tobacco, Hypercium, Eucalyptus, Pepermint etc. The herbal drugs which are used for the treatment of AIDS are Kalmegh, Betel nut, Turmeric, Clove, Liquorice etc. The herbal drugs which are used for the treatment of Liver disorders are Liquorice, Milk thistle, Liv-52, Green tea etc. Many compounds of plant origin that inhibits various stages of cell cycle which includes several alkaloids, carbohydrates, coumarine, flavanoids, lignin, phenolics, proteins, cunnins, xanthenes, phospholipids and tannins. These candidates have the potential to come up as a drug for treatment for various diseases. So the aim of this review article is to identify plants and their active principles possessing activities against Viral infection, HIV, and Liver disorders with the objective of providing an effective approach for prevention of transmission and treatment of these diseases.

Pages: 08-18  |  1553 Views  734 Downloads


International Journal of Pharmacognosy and Clinical Research
How to cite this article:
Goswami Raksha, Kumawat Deepak, Gupta Durgesh Kumari, Shrivastava Darshana, Kumawat Priyanka. A review on hebral remedies used for viral infection, HIV and liver disorder. Int. J. Pharmacogn. Clin. Res. 2019;1(1):08-18. DOI: 10.33545/2664763X.2019.v1.i1a.1
Call for book chapter